Patient-Reported Cognitive Impairment among Women with Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results from TAILORx

Lynne I. Wagner*, Robert J. Gray, Joseph A. Sparano, Timothy J. Whelan, Sofia F. Garcia, Betina Yanez, Amye J. Tevaarwerk, Ruth C. Carlos, Kathy S. Albain, John A. Olson, Matthew P. Goetz, Kathleen I. Pritchard, Daniel F. Hayes, Charles E. Geyer, E. Claire Dees, Worta J. McCaskill-Stevens, Lori M. Minasian, George W. Sledge, David Cella

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

65 Scopus citations

Fingerprint

Dive into the research topics of 'Patient-Reported Cognitive Impairment among Women with Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results from TAILORx'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Psychology